Moffitt logo

Articles related to Multiple Myeloma-Plasma Cell Cancer


New Study Finds "Off the Shelf CAR-T" Promising for Certain Lymphoma Patients

Moffitt is one of a few hospitals nationwide testing ALLO-501a, an allogeneic CAR T therapy product from Allogene Therapeutics, in combination with ALLO-64 Read More


Comprehensive Molecular Profiling of Undifferentiated Embryonal Sarcoma of the Liver

Moffitt Cancer Center is leading the research in rare sarcomas and has performed the most comprehensive molecular analysis to-date of undifferentiated embryonal sarcoma of the liver Read More


Reshaping the Frontline Treatment Landscape of ES-SCLC

Dr. Bruna Pellini, in an interview with OncLive®, also compares the findings of the CASPIAN and IMpower133 trials and research efforts currently ongoing in ES-SCLC Read More

Moffitt Cancer Center Thoracic 13

Improving Representation of Racial and Ethnic Minorities in Lung Cancer Screening Programs

With recent screening guidelines changes, more people are eligible for a low-dose CT scan and have the ability to participate in lung screening programs or trials. Read More


CAR T Clinical Trials for Multiple Myeloma Bring Promising New Treatments

Moffitt researchers are leaders in advancing the field of CAR T therapy and multiple myeloma clinical trials provide patients with exciting new treatment opportunities. Read More


March Is Multiple Myeloma Awareness and Action Month

Exactly what is multiple myeloma? Even though it is the second most common form of blood cancer, many people have never heard of it. Read More